These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34135617)

  • 1. High Fibroblast Growth Factor 23 as a Biomarker for Severe Cardiac Impairment in Children with Chronic Kidney Disease: A Single Tertiary Center Study.
    Palupi-Baroto R; Hermawan K; Murni IK; Nurlitasari T; Prihastuti Y; Sekali DRK; Ambarsari CG
    Int J Nephrol Renovasc Dis; 2021; 14():165-171. PubMed ID: 34135617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
    Akhabue E; Wong M; Mehta R; Isakova T; Wolf M; Yancy C; Gutierrez OM; Carnethon M
    Am Heart J; 2022 Mar; 245():10-18. PubMed ID: 34861237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
    Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23.
    Yan L; Bowman MA
    Inflamm Cell Signal; 2014; 1(5):. PubMed ID: 26082935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
    Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Correlation of Fibroblast Growth Factor 23 with Cardiac Remodeling in Essential Hypertension with Normal Renal Function.
    Han J; Yuan X; Song W; Cheng Y; Lu Y; Zhang Y; Liu Y; Jiang Y
    Cardiology; 2022; 147(3):271-280. PubMed ID: 35500559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy.
    Okamoto K; Fujii H; Watanabe K; Goto S; Kono K; Nishi S
    J Endocr Soc; 2022 Feb; 6(2):bvab187. PubMed ID: 35047715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease-A Pediatric Perspective.
    Grund A; Sinha MD; Haffner D; Leifheit-Nestler M
    Front Pediatr; 2021; 9():702719. PubMed ID: 34422725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease.
    Bacharaki D; Petrakis I; Kyriazis P; Markaki A; Pleros C; Tsirpanlis G; Theodoridis M; Balafa O; Georgoulidou A; Drosataki E; Stylianou K
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H; Choi HJ; Kang HG; Ha IS; Cheong HI; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS
    Kidney Blood Press Res; 2017; 42(3):406-415. PubMed ID: 28689198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
    Di Marco GS; Reuter S; Kentrup D; Grabner A; Amaral AP; Fobker M; Stypmann J; Pavenstädt H; Wolf M; Faul C; Brand M
    Nephrol Dial Transplant; 2014 Nov; 29(11):2028-35. PubMed ID: 24875663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Left Ventricular Geometry, Systolic Ejection Time, and Estimated Glomerular Filtration Rate in Ambulatory Patients with Preserved Left Ventricular Ejection Fraction.
    Goeddel LA; Navarrete S; Waldron N; D'Amiano A; Faraday N; Lima JAC; Parikh CR; Bandeen-Roche K; Hays AG; Brown Iv C
    Cardiology; 2024 Oct; ():1-11. PubMed ID: 39353411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 induces left ventricular hypertrophy.
    Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
    J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.